SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market sentiment for the S&P 500 is heavily focused on the upcoming Federal Reserve interest rate decision, with traders debating whether persistent inflation and geopolitical tensions in the Middle East will force a hawkish stance. The community is actively discussing the potential for a "nothing burger" outcome versus a volatile market reaction as participants weigh the impact of higher oil prices and stagnant rate projections on the broader bull trend.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing significant momentum as it heads into its quarterly earnings report, with investors focused on the company's critical role in the AI memory supply chain and its capacity to meet demand for HBM chips. While some community members anticipate a massive breakout or a stock split, others are closely watching for potential profit-taking and volatility given the stock's substantial run-up and high implied move expectations.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing intense trading activity as retail and institutional investors debate whether the stock's massive year-to-date rally is justified by surging AI-driven memory demand or is an unsustainable bubble prone to a sharp reversal. The community is heavily focused on upcoming sector catalysts and Micron's earnings report, with bullish traders betting on continued supply shortages while bearish speculators remain active in calling for a significant pullback.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing significant upward momentum driven by aggressive institutional buying and speculative interest in the edge computing and AI sector. The community remains deeply divided, with bulls pointing to the stock's resilience and growth potential, while skeptics warn of market manipulation, heavy insider selling, and a lack of fundamental profitability.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is experiencing heightened market activity driven by anticipation of upcoming US patent approvals for its Precision Timed Release technology and a pending PDUFA date in late May for its ADHD therapeutic, CTx-1301. Community sentiment remains largely bullish, with investors focusing on the company's low float, institutional accumulation, and the potential for a significant revaluation as the company moves toward commercialization.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is experiencing extreme volatility and heavy retail interest following an explosive IPO, with the community actively debating whether the company's defense-focused drone software and battlefield-proven narrative justify its massive valuation relative to its current financials. Traders are closely watching for potential breakouts past psychological resistance levels, with many speculating on the potential for institutional contracts and multi-day momentum similar to past high-hype market runners.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm Holdings is currently facing heightened volatility and selling pressure as the market re-evaluates the fintech sector amid concerns over credit losses and a cooling growth outlook for gross merchandise volume. While community members remain dividedwith some viewing the recent price drop as a buying opportunity given the company's path to GAAP profitability and strategic partnerships, others are concerned about macroeconomic headwinds and the stock's high sensitivity to broader market sentiment.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing high volatility as investors react to a combination of strong earnings, recent insider buying, and significant institutional interest from funds like Cathie Wood's ARK. The community is actively debating the stock's future, weighing potential short-squeeze dynamics against ongoing concerns about competitive pressures and software sector valuation.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing high volatility as the market reacts to shifting geopolitical tensions and the upcoming quarterly earnings report. The community is heavily focused on the company's progress with its USV maritime technology and the expectation of future government defense contracts.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are currently under intense pressure as investors react to a downward revision in full-year guidance and persistent uncertainty surrounding the ongoing CEO search. While some market participants see value in the stock at current multiples, the community remains divided between those bracing for a deeper retracement and those betting on a potential turnaround following long-standing activist involvement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jain Global LLC Takes Position in Xenon Pharmaceuticals Inc. $XENE

Jain Global LLC bought a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 252,379...

Holocene Advisors LP Acquires 167,078 Shares of Xenon Pharmaceuticals Inc. $XENE

Holocene Advisors LP boosted its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 9.2% in the third quarter, according to the company in its most recent 13F filing with...

Xenon Pharmaceuticals Inc. $XENE Shares Sold by Granahan Investment Management LLC

Granahan Investment Management LLC decreased its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 63.6% during the third quarter, according to the company in its most recent...

Cinctive Capital Management LP Takes Position in Xenon Pharmaceuticals Inc. $XENE

Cinctive Capital Management LP purchased a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) in the third quarter, according to the company in its most recent disclosure with the...

Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Cut to $63.00 by Analysts at Wedbush

Wedbush decreased their price objective on Xenon Pharmaceuticals from $64.00 to $63.00 and set an "outperform" rating for the company in a report on Monday...

HighVista Strategies LLC Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE

HighVista Strategies LLC boosted its stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 80.2% in the third quarter, according to its most recent filing with the Securities and...

Commodore Capital LP Has $108.41 Million Position in Xenon Pharmaceuticals Inc. $XENE

Commodore Capital LP trimmed its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 10.7% during the 3rd quarter, according to its most recent disclosure with the...

Christopher John Kenney Sells 1,410 Shares of Xenon Pharmaceuticals (NASDAQ:XENE) Stock

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) insider Christopher John Kenney sold 1,410 shares of the company's stock in a transaction dated Friday, March 13th. The stock was sold at an...

Xenon Pharmaceuticals (NASDAQ:XENE) Insider Andrea Difabio Sells 1,342 Shares

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) insider Andrea Difabio sold 1,342 shares of the stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average...

Xenon Pharmaceuticals (NASDAQ:XENE) CEO Sells $403,620.84 in Stock

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) CEO Ian Mortimer sold 7,308 shares of the company's stock in a transaction on Friday, March 13th. The stock was sold at an average price of...

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

XENE
Xenon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest XENE News

XENEXenon Pharmaceuticals Inc